Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond
出版年份 2021 全文链接
标题
Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond
作者
关键词
-
出版物
Cells
Volume 10, Issue 4, Pages 951
出版商
MDPI AG
发表日期
2021-04-21
DOI
10.3390/cells10040951
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inflammatory Chemokines in Atherosclerosis
- (2021) Selin Gencer et al. Cells
- NLRP3 inflammasome as a key driver of vascular disease
- (2021) Masafumi Takahashi CARDIOVASCULAR RESEARCH
- Functional Role of B Cells in Atherosclerosis
- (2021) Shelby D. Ma et al. Cells
- Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study
- (2021) Tian X Zhao et al. CARDIOVASCULAR RESEARCH
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality
- (2021) Stefan J Schunk et al. EUROPEAN HEART JOURNAL
- The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
- (2021) Trevor P. Fidler et al. NATURE
- Antibody-based immunotherapy targeting cytokines and atherothrombotic cardiovascular diseases
- (2020) Hafid Ait-Oufella et al. Archives of Cardiovascular Diseases
- Vaccination Strategies and Immune Modulation of Atherosclerosis
- (2020) Jan Nilsson et al. CIRCULATION RESEARCH
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial
- (2020) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- Postischemic Administration of IL-1α Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke
- (2020) Luca Liberale et al. CIRCULATION
- Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy
- (2020) Tjerk S.J. Opstal et al. CIRCULATION
- COVID-19 is, in the end, an endothelial disease
- (2020) Peter Libby et al. EUROPEAN HEART JOURNAL
- Inherited causes of clonal haematopoiesis in 97,691 whole genomes
- (2020) Alexander G. Bick et al. NATURE
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 – A vascular disease
- (2020) Hasan K. Siddiqi et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Inflammation in Atherosclerosis—No Longer a Theory
- (2020) Peter Libby CLINICAL CHEMISTRY
- Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
- (2020) Allan L. Klein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T Cell Stability and Plasticity in Atherosclerosis
- (2020) Amal J. Ali et al. Cells
- Vaccination in Atherosclerosis
- (2020) Felix Sebastian Nettersheim et al. Cells
- Monocyte Recruitment, Specification, and Function in Atherosclerosis
- (2020) Ki-Wook Kim et al. Cells
- CD8+ T Cells in Atherosclerosis
- (2020) Sarah Schäfer et al. Cells
- Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 V617F Mice
- (2019) Wei Wang et al. CIRCULATION RESEARCH
- The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse
- (2019) Stefano Toldo et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis
- (2019) Amélie Vromman et al. EUROPEAN HEART JOURNAL
- Targeting the Immune System in Atherosclerosis
- (2019) Tian X. Zhao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction
- (2019) Leo F. Buckley et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk
- (2019) Hafid Ait-Oufella et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
- (2019) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- Genetic IL-6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis
- (2019) Alexander G. Bick et al. CIRCULATION
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
- (2019) Stephen Zewinger et al. NATURE IMMUNOLOGY
- Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1α and Cathepsin G
- (2018) Eduardo J. Folco et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- OUP accepted manuscript
- (2018) CARDIOVASCULAR RESEARCH
- All roads lead to IL-6: A central hub of cardiometabolic signaling
- (2018) Peter Libby et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction
- (2018) Ola Kleveland et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- HSP27 immunization attenuates atherogenesis by markedly reducing plasma PCSK9 and cholesterol levels
- (2018) E. O'Brien et al. ATHEROSCLEROSIS
- Interleukin-6 Trans-Signaling and Risk of Future Cardiovascular Events: A New Avenue for Atheroprotection?
- (2018) Giuseppe Ferrante et al. CARDIOVASCULAR RESEARCH
- Tumor Necrosis Factor-α in Heart Failure: an Updated Review
- (2018) Sarah M. Schumacher et al. Current Cardiology Reports
- Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction
- (2018) Hilde E. Groot et al. Clinical Research in Cardiology
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anakinra Therapy for Non-cancer Inflammatory Diseases
- (2018) Giulio Cavalli et al. Frontiers in Pharmacology
- Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms
- (2017) Charles N. Serhan FASEB JOURNAL
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
- (2017) José J. Fuster et al. SCIENCE
- Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
- (2017) Claes Held et al. Journal of the American Heart Association
- Inflammation, remodeling, and other factors affecting HDL cholesterol efflux
- (2016) Graziella E. Ronsein et al. CURRENT OPINION IN LIPIDOLOGY
- Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
- (2016) Ola Kleveland et al. EUROPEAN HEART JOURNAL
- Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction
- (2016) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Test in Context
- (2016) Paul M Ridker JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction
- (2015) Ilais Moreno Velásquez et al. ATHEROSCLEROSIS
- Innate Immunity and the Failing Heart
- (2015) Douglas L. Mann CIRCULATION RESEARCH
- High dose and long-term statin therapy accelerate coronary artery calcification
- (2015) Michael Henein et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cholesterol Crystals Associate With Coronary Plaque Vulnerability In Vivo
- (2015) Yu Kataoka et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Statins on Serial Coronary Calcification During Atheroma Progression and Regression
- (2015) Rishi Puri et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter
- (2015) Jing Wang et al. NATURE MEDICINE
- Moderate Hypoxia Potentiates Interleukin-1β Production in Activated Human Macrophages
- (2014) Eduardo J. Folco et al. CIRCULATION RESEARCH
- Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
- (2014) Peter Libby et al. CIRCULATION RESEARCH
- TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
- (2014) Lisa M. Sedger et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
- (2014) A. C. Morton et al. EUROPEAN HEART JOURNAL
- Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
- (2014) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vaccine for Atherosclerosis
- (2014) Prediman K. Shah et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis
- (2014) Jonathan D. Brown et al. MOLECULAR CELL
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Atheroprone Flow Activation of the Sterol Regulatory Element Binding Protein 2 and Nod-Like Receptor Protein 3 Inflammasome Mediates Focal Atherosclerosis
- (2013) Jun-ichi Abe et al. CIRCULATION
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Fatty acid–induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis
- (2013) Stefan Freigang et al. NATURE IMMUNOLOGY
- A Randomized Trial of Colchicine for Acute Pericarditis
- (2013) Massimo Imazio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor necrosis factor
- (2012) Wen-Ming Chu CANCER LETTERS
- NF-κB as a Target for Modulating Inflammatory Responses
- (2012) Chiara Gasparini et al. CURRENT PHARMACEUTICAL DESIGN
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Recent Advances on the Role of Cytokines in Atherosclerosis
- (2011) Hafid Ait-Oufella et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
- (2011) Harald Schuett et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1α
- (2011) Yehuda Kamari et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- NF-κB is 25
- (2011) David Baltimore NATURE IMMUNOLOGY
- Integrated safety in tocilizumab clinical trials
- (2011) Michael H Schiff et al. ARTHRITIS RESEARCH & THERAPY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- How much is too much? Interleukin-6 and its signalling in atherosclerosis
- (2009) Harald Schuett et al. THROMBOSIS AND HAEMOSTASIS
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model
- (2007) Monika Madan et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search